Project Grant R01EB036575
- Federal Grant Award Summary Vanderbilt University Medical Center received a $481,250 Project Grant from the National Institute of Biomedical Imaging and Bioengineering under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The award, effective September 1, 2025, through August 31, 2027, funds the development of an innovative radiofrequency (RF) coil array specifically designed for magnetic resonance-guided focused ultrasound (MRGFUS)...
- Federal Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded the University of Maryland, Baltimore a $516,628 Project Grant effective June 1, 2026, through March 31, 2030, under CFDA 93.286 (Discovery and Applied Research for Technological Innovations to Improve Human Health). The grant supports the development of motion correction techniques for single-shot diffusion-weighted magnetic resonance imaging (DWI) of the brain. The project will deliver a...
- Federal Project Grant Award Summary Vanderbilt University Medical Center (VUMC) received a $843,434 Project Grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), awarded August 15, 2025, with completion targeted for April 30, 2029. The project, "Advancing Machine Learning for CEST MRI Analysis through Partially Synthetic Data," focuses on...
- Federal Grant Award Summary Award Details: The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded Boston Children's Hospital a Project Grant of $996,466 under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The award commenced August 1, 2025, with a completion date of May 31, 2029. Deliverables: This project will develop and validate an innovative motion- and distortion-robust quantitative MRI (QMRI) imaging...
- Federal Grant Award Summary Grant Overview The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded Vanderbilt University a $542,947 Project Grant (CFDA 93.286: Discovery and Applied Research for Technological Innovations to Improve Human Health) effective March 3, 2026, through February 28, 2030, to develop fully non-invasive transcranial functional ultrasound imaging for adult humans. This research addresses a critical public health need by advancing a low-cost,...
- Federal Project Grant Award Summary Vanderbilt University Medical Center received a $700,000 Project Grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), awarded August 8, 2025, with completion by July 31, 2028. This award supports the development of novel radiosynthesis methods using direct [11C]CO2 methylation for production of carbon-11...
- This $1,336,000 Project Grant awarded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the CFDA 93.286 "Discovery and Applied Research for Technological Innovations to Improve Human Health" program supports the development of a rapid, motion-robust, and low-gadolinium MRI technology for pediatric brain tumors. The key objectives are to (1) develop cutting-edge technologies for rapid, motion-robust, and quantitative MRI scans to reduce sedation needs...
- Federal Grant Award Summary The Regents of the University of Minnesota received a $531,021 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), with an award date of April 10, 2026, and ultimate completion date of January 31, 2030. The project focuses on developing advanced technology solutions to optimize a 10.5 Tesla (10.5T)...
- Federal Project Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded Massachusetts General Hospital $269,460 under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) for the period August 1, 2025 through July 31, 2027. The award funds research and development of advanced magnetic resonance imaging (MRI) acquisition and analysis methods designed to enhance the detection and...
- Federal Grant Award Summary Vanderbilt University received a $2.22 million Project Grant from the National Institute of Biomedical Imaging and Bioengineering under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop an augmented reality (AR) guidance system with deformation modeling for head and neck tumor resection. The project, awarded August 5, 2025, with completion targeted for July 31, 2029, addresses the clinical...
Vanderbilt University Medical Center received a $499,651 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), effective June 4, 2026, with completion targeted for March 31, 2030. This grant funds the development and validation of a real-time head motion correction system for brain magnetic resonance imaging (MRI) utilizing inductively coupled wireless nuclear magnetic resonance (NMR) probes. The project will deliver technical innovations including rapid ultrashort echo navigators, optimized probe designs with tuned relaxivities, real-time filtering and shimming capabilities, and channel-wise data processing algorithms designed to enhance motion correction robustness across multiple neuroimaging sequences. The grant deliverables encompass two primary aims: fabrication of wireless NMR probes coupled with software and hardware development for phantom validation in structural and functional MRI scans; and clinical validation demonstrating motion correction effectiveness for both voluntary and involuntary head motions in healthy adults and typically developing children. The system will be validated across two leading vendor platforms—Philips and Siemens—at 3 Tesla field strength, with particular emphasis on pediatric imaging applications where head motion presents significant diagnostic challenges. The prospective correction technology is designed to be cost-effective, robust, and implementable across vendor platforms with plug-and-play operational characteristics.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $499.7k | 6/9/26 |